A new study reveals that activating a specific dopamine receptor in the brain can blunt the inflammatory response triggered by REM sleep loss in mice. The finding points to a molecular circuit connecting sleep deprivation, brain immune cells, and the dopamine signaling system that could eventually inform strategies for protecting the brain against the harmful effects of chronic sleep loss.
The Mechanism: From Sleep Loss to Inflammation, Step by Step
REM sleep deprivation is known to trigger neuroinflammation, but the chain of events from lost sleep to inflamed brain tissue involves multiple cell types and signaling molecules. The study, published in Cells, traced this chain in male CD1 mice subjected to 72 hours of REM sleep deprivation and then tested whether a drug called quinpirole could interrupt it.
Step 1: REM Sleep Deprivation Activates Glial Cells
After three days without REM sleep, the mice showed elevated levels of two key markers. GFAP, a protein associated with astrocytes, increased in brain tissue, indicating that these supportive glial cells were responding to the stress of sleep loss. More notably, Iba-1, a marker expressed by microglia (the brain’s resident immune cells), also rose significantly. Microglia are the first line of immune defense in the central nervous system, and their activation is a hallmark of neuroinflammation.
Step 2: Microglia Change Shape as They Activate
Resting microglia have a branched, ramified morphology that allows them to survey their surroundings. When activated, they retract those branches and take on a more amoeboid shape. The researchers observed exactly this transformation in the hippocampus and cortex of REM sleep-deprived mice. The morphological shift confirmed that microglia were not merely present but were actively responding to the physiological disruption caused by sleep loss.
Step 3: NF-kB, the Inflammation Master Switch, Translocates to the Nucleus
At the molecular level, the study zeroed in on NF-kB, a transcription factor that acts as a central regulator of inflammation. Under normal conditions, NF-kB is held inactive in the cytoplasm. Inflammatory signals trigger its translocation to the nucleus, where it turns on genes for pro-inflammatory cytokines and other immune mediators.
In the REM sleep-deprived mice, NF-kB nuclear expression increased specifically within microglia across multiple brain regions: hippocampal CA1, CA3, the dentate gyrus, and the medial parietal cortex. This nuclear translocation is the critical step where sleep deprivation translates into a pro-inflammatory transcriptional program inside brain immune cells.
Step 4: Quinpirole Activates D2 Dopamine Receptors on Microglia
This is where the dopaminergic system enters the picture. Quinpirole is a selective agonist of D2-like dopamine receptors (DRD2). Dopamine is primarily known for its roles in reward, motivation, and movement, but D2 receptors are also expressed on microglia. The researchers administered quinpirole (2 mg/kg/day) to both normally rested and REM sleep-deprived mice to see whether DRD2 activation could influence the neuroinflammatory cascade.
Step 5: DRD2 Activation Suppresses Microglial Activation
Quinpirole treatment significantly reduced Iba-1 expression in the brains of REM sleep-deprived mice. The drug also attenuated the morphological changes associated with microglial activation, helping the cells retain a more ramified, survey-capable shape rather than shifting to the amoeboid, inflammatory phenotype.
Step 6: Quinpirole Blocks NF-kB Nuclear Entry
Most importantly, quinpirole reduced NF-kB nuclear expression in microglia across all the brain regions examined. Even in mice undergoing active REM sleep deprivation, D2 receptor activation was sufficient to suppress the translocation of this inflammation master switch. The effect was consistent across hippocampal subfields and the cortex, suggesting that DRD2 signaling exerts a broad anti-inflammatory influence on microglia throughout the forebrain.
Why It Matters
Sleep loss is increasingly recognized as a risk factor for neurodegenerative diseases including Alzheimer’s and Parkinson’s disease. Chronic neuroinflammation driven by activated microglia is a common thread linking poor sleep to long-term brain health decline. If D2 dopamine receptor activation can suppress microglial inflammation during sleep deprivation, it opens a potential pharmacological avenue for mitigating these risks.
The finding is also notable because it links two systems that are not often considered together in the sleep field: the dopaminergic reward/motor system and the brain’s innate immune response. Dopamine signaling, long studied for its roles in Parkinson’s disease and psychiatric disorders, may have an overlooked function as a brake on neuroinflammation triggered by physiological stressors.
Limits
As a mouse study, direct translation to humans remains uncertain. The experiment used only male CD1 mice, and sex differences in both sleep regulation and immune responses are well documented. The study also relied on a single drug at a single dose, and quinpirole activates both D2 and D3 receptor subtypes, so the specific contribution of each remains unclear. The 72-hour REM sleep deprivation protocol is an extreme model that does not mirror typical human sleep loss patterns. Finally, the study measured protein expression and cellular morphology but did not directly measure cytokine production or behavioral outcomes, so the functional consequences of the observed molecular changes remain to be established.
Bottom Line
Activating D2-like dopamine receptors with quinpirole suppresses microglial activation and blocks NF-kB nuclear translocation in the brains of REM sleep-deprived mice. The dopaminergic system may offer a target for reducing the neuroinflammatory burden associated with chronic sleep loss.
Source
Ugalde-Muñiz P, Olvera-Valderrabano Y, Lugo-Huitrón R, Landa A, Navarro L. Quinpirole, a D2-like Dopaminergic Receptor Agonist, Regulates Neuroinflammation and Reduces NF-kappaB Nuclear Expression in Microglia from Hippocampus and Brain Cortex Induced by Rapid Eye Movement Sleep Deprivation in Mice. Cells. 2026;15(13):1224. DOI: 10.3390/cells15131224. PMID: 42439698.